Broken drug markets in infectious diseases: Opportunities outside the private sector?

A subset of anti-infective drugs are increasingly unavailable for patients in the United States due to pricing or withdrawal from the market. Timely market solutions are needed. We assert that solutions to ensure access to some essential anti-infective agents lie outside capital markets and that pub...

Descripción completa

Detalles Bibliográficos
Autores principales: Alpern, Jonathan D., Dunlop, Stephen J., Stauffer, William M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Viewpoints
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6459471/
https://www.ncbi.nlm.nih.gov/pubmed/30973876
http://dx.doi.org/10.1371/journal.pntd.0007190
Descripción
Sumario:A subset of anti-infective drugs are increasingly unavailable for patients in the United States due to pricing or withdrawal from the market. Timely market solutions are needed. We assert that solutions to ensure access to some essential anti-infective agents lie outside capital markets and that public-private partnerships may be the most viable solution.

Ejemplares similares